The content on this site is intended for healthcare professionals only
Dr Pastorino presents at the Future Horizons in Lung Cancer meeting about current state of the art surgery in lung cancer.
TROP2 expression measured by QCS is a promising predictor of clinical outcomes in patients with mNSCLC
Biomarkers, predictive and prognostic factors of resistance to immunotherapy
Uncommon genetic aberrations NTRK, RET, NRG
Innovative treatments for solid tumours – TTFields as a therapeutic modality
Feasibility and safety of boost at 74 Gy based on interim FDG-PET during thoracic radio-chemotherapy for NSCLC patients
Neoadjuvant cemiplimab shows favourable event-free, disease-free and overall survival rates in patients with resectable CSCC
Adagrasib shows durable clinical benefit in advanced KRAS-mutant NSCLC
The 5-year long-term outcomes of radiation technique for locally advanced NSCLC
War in Ukraine: The Global Medical Knowledge Alliance's response to improving cancer care
